Home » Psychology news » Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders
Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders
May 20, 2022 by NewsBot
Scientists have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.
